Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Rillamas-Sun E, Kwan ML, Carlos C, Cheng R, Neugebauer R, Rana JS, Nguyen-Huynh M, Shi Z, Laurent CA, Lee VS, Roh JM, Huang Y, Shen H, Hershman DL, Kushi LH, Greenlee H.
Rillamas-Sun E, et al. Among authors: lee vs.
Res Sq [Preprint]. 2023 Mar 22:rs.3.rs-2675372. doi: 10.21203/rs.3.rs-2675372/v1.
Res Sq. 2023.
PMID: 36993531
Free PMC article.
Updated.
Preprint.